Literature DB >> 2341177

Inoculation of barrier-born pigs with Helicobacter pylori: a useful animal model for gastritis type B.

L Engstrand1, S Gustavsson, A Jörgensen, A Schwan, A Scheynius.   

Abstract

At the age of 8 weeks, 15 barrier-born pigs, specific pathogen free, were inoculated intragastrically with suspensions of 10(7) to 10(10) CFU of Helicobacter pylori after pretreatment with omeprazole. The pigs were observed for up to 12 weeks, endoscopic biopsy specimens were taken, and serum samples were drawn. H. pylori was identified by routine culturing and by staining with an H. pylori-specific monoclonal antibody on cryostat sections of gastric biopsy specimens. In 11 of 15 inoculated pigs, H. pylori was detected throughout the observation period. In these infected pigs, there was an antibody response to H. pylori, as determined in serum by an enzyme immunoassay. Furthermore, the development of superficial, focal gastritis with infiltrates of mononuclear class II antigen-expressing lymphocytes was observed immunohistologically. H. pylori was never detected and an antibody response to H. pylori was not observed in two control pigs. The development of gastritis and the systemic antibody response to H. pylori support the usefulness of this animal model for studies of H. pylori-related human diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2341177      PMCID: PMC258720          DOI: 10.1128/iai.58.6.1763-1768.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Attempt to fulfil Koch's postulates for pyloric Campylobacter.

Authors:  B J Marshall; J A Armstrong; D B McGechie; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

2.  Monoclonal antibodies for rapid identification of Campylobacter pyloridis.

Authors:  L Engstrand; C Pählson; S Gustavsson; A Schwan
Journal:  Lancet       Date:  1986-12-13       Impact factor: 79.321

3.  In search of an animal model for experimental Campylobacter pylori infection: administration of Campylobacter pylori to rodents.

Authors:  S Ehlers; M Warrelmann; H Hahn
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1988-05

4.  Endoscopic evaluations of potentially ulcerogenic drugs. A new in vivo porcine test model.

Authors:  H Hey; T Wamberg; M Rasmussen; F Jørgensen
Journal:  Eur Surg Res       Date:  1987       Impact factor: 1.745

5.  Monoclonal anti-Ia murine alloantibodies crossreactive with the Ia-homologues of other mammalian species including humans.

Authors:  M Watanabe; T Suzuki; M Taniguchi; N Shinohara
Journal:  Transplantation       Date:  1983-12       Impact factor: 4.939

6.  Establishment of gastric Campylobacter pylori infection in the neonatal gnotobiotic piglet.

Authors:  S Krakowka; D R Morgan; W G Kraft; R D Leunk
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

7.  Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study.

Authors:  J G Coghlan; D Gilligan; H Humphries; D McKenna; C Dooley; E Sweeney; C Keane; C O'Morain
Journal:  Lancet       Date:  1987-11-14       Impact factor: 79.321

8.  Campylobacter pylori: clinical, histological, and serological studies.

Authors:  C Musgrove; F J Bolton; A M Krypczyk; J M Temperley; S A Cairns; W G Owen; D N Hutchinson
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

Review 9.  Campylobacter pylori and peptic ulcer disease.

Authors:  D Y Graham
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

10.  Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells.

Authors:  L Engstrand; A Scheynius; C Påhlson; L Grimelius; A Schwan; S Gustavsson
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

View more
  12 in total

1.  Helicobacter mustelae-induced gastritis and elevated gastric pH in the ferret (Mustela putorius furo).

Authors:  J G Fox; G Otto; N S Taylor; W Rosenblad; J C Murphy
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Pathological changes in the formation of Helicobacter pylori-induced gastric lesions in Mongolian gerbils.

Authors:  S Takahashi; Y Keto; H Fujita; H Muramatsu; T Nishino; S Okabe
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

Review 3.  Helicobacter pylori and its reservoirs: A correlation with the gastric infection.

Authors:  Spencer Luiz Marques Payão; Lucas Trevizani Rasmussen
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

4.  Immunomagnetic separation and PCR for detection of Helicobacter pylori in water and stool specimens.

Authors:  H Enroth; L Engstrand
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

Review 5.  Helicobacter pylori and peptic ulcer disease.

Authors:  M Feldman; W L Peterson
Journal:  West J Med       Date:  1993-11

6.  Adhesion of Helicobacter pylori to gastric epithelial cells in primary cultures obtained from stomachs of various animals.

Authors:  Y Kobayashi; K Okazaki; K Murakami
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

7.  Experimental gastritis induced by Helicobacter pylori in Japanese monkeys.

Authors:  R Shuto; T Fujioka; T Kubota; M Nasu
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

8.  Topographic mapping of Helicobacter pylori colonization in long-term-infected pigs.

Authors:  L Engstrand; K Rosberg; R Hübinette; T Berglindh; W Rolfsen; S Gustavsson
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

9.  A euthymic hairless mouse model of Helicobacter pylori colonization and adherence to gastric epithelial cells in vivo.

Authors:  N Kimura; M Ariga; F C Icatlo; M Kuroki; M Ohsugi; Y Ikemori; K Umeda; Y Kodama
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

10.  13C-urea breath test for diagnosis of experimental Helicobacter pylori infection in barrier born pigs.

Authors:  K Meyer-Rosberg; S Gustavsson
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.